If your desire for intimacy has quietly disappeared—leaving you wondering where “you” went—you’re not alone. Female sexual dysfunction affects a significant number of women depending on age and hormonal status, yet most suffer in silence because they’ve been told it’s “normal” or “just stress.” The truth is, low libido often stems from real physiological causes—hormone imbalances affecting brain chemistry, neurotransmitter disruptions, and relational disconnection. Inner Balance addresses these root causes through comprehensive solutions like Oestra™ for hormonal restoration and Libida™ for on-demand desire support, giving women evidence-based options that work with their bodies rather than against them.
Key Takeaways
- HSDD is a real diagnosis: Hypoactive Sexual Desire Disorder requires both absent/reduced desire AND personal distress—not just low frequency of sexual activity
- Hormones are foundational: Estrogen, progesterone, and testosterone all influence desire pathways in the brain, and imbalances can significantly impact libido
- Brain-based treatments work: Bremelanotide targets melanocortin receptors in the hypothalamus to boost dopamine and restore the neurological “spark” of desire
- Dual-pathway approach is superior: Combining neurochemical desire activation with emotional bonding pathways reflects how women’s sexuality actually works
- On-demand options exist: Unlike daily pills requiring alcohol abstinence, sublingual formulations allow women to use treatment only when needed
Libida™ is a brain-based libido booster for women – no hormones, meds, or injections. One dissolvable tablet to bring the spark back, on your terms.
HSA/FSA Eligible •
Free shipping • Cancel anytime
Understanding HSDD and FSAD: More Than “Just Not in the Mood”
What Is Hypoactive Sexual Desire Disorder?
HSDD isn’t simply having a lower sex drive than your partner or feeling tired after a long day. It’s a clinical diagnosis defined as persistent or recurrent deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty.
The key word is distress. If you’re content with less frequent intimacy, that’s not dysfunction—it’s preference. But if you find yourself grieving the loss of desire, feeling disconnected from your partner, or wondering what happened to the woman who once felt passionate, that internal distress matters clinically.
Symptoms that point toward HSDD include:
- Absent or reduced interest in sexual activity
- Lack of sexual thoughts or fantasies
- Decreased initiation of intimacy
- Reduced excitement or pleasure during sexual encounters
- Diminished response to erotic cues that previously sparked interest
What Is Female Sexual Arousal Disorder?
While HSDD centers on desire—the mental wanting of sexual connection—FSAD involves the body’s response: inability to attain or maintain adequate lubrication and physical arousal despite being mentally interested. Many women experience both conditions simultaneously, which is why the DSM-5 combined them into Female Sexual Interest/Arousal Disorder (FSIAD).
The distinction matters for treatment selection. If your body responds physically but your mind feels disconnected, targeting brain pathways makes sense. If you want intimacy but experience dryness and physical discomfort, addressing tissue health through hormone therapy becomes the priority.
Impact on Quality of Life
Research consistently shows female sexual dysfunction significantly affects overall well-being, self-esteem, relationship satisfaction, and mental health. Women with untreated HSDD report higher rates of depression, anxiety, and relationship conflict—yet many never seek help because they’ve internalized the message that their sexuality doesn’t matter as much after a certain age.
It does matter. Your desire for connection, pleasure, and intimacy is valid at every life stage.
How Hormonal Imbalances Affect Libido
The Hormonal Foundation of Desire
Sexual desire doesn’t originate in your reproductive organs—it begins in your brain, where hormones act as chemical messengers influencing neurotransmitter activity. Understanding this connection explains why hormonal imbalances so profoundly impact libido.
Estrogen influences serotonin and dopamine—neurotransmitters directly tied to mood, motivation, and pleasure-seeking behavior. When estrogen levels drop during perimenopause or menopause, women often experience:
- Decreased genital sensation
- Reduced blood flow to sexual tissues
- Vaginal dryness making intercourse uncomfortable
- Mood changes that diminish interest in intimacy
Progesterone supports the calming GABA pathways in your brain, helping regulate anxiety and promote relaxation—both essential for sexual receptivity. Women with low progesterone often feel too anxious or wired to relax into intimacy.
Testosterone—yes, women need it too—directly influences sexual desire, arousal, and orgasm intensity. Levels decline gradually with age, and precipitously after surgical menopause.
When Hormones Are Optimized But Desire Remains Flat
Here’s what many women don’t realize: you can address hormonal imbalances and still experience low desire. That’s because hormones provide the foundation, but the neurological pathways that generate actual wanting—the mental spark that makes you think about and anticipate intimacy—operate somewhat independently.
This explains why some women feel physically better on hormone therapy yet wonder, “Why don’t I ever want it?” Their tissue health improved, but the brain circuits responsible for desire activation remain dormant.
This is precisely where targeted neurological interventions become essential.
Non-Hormonal Approaches for Boosting Desire and Arousal
Targeting the Brain: Where Desire Actually Originates
Female desire isn’t a simple on/off switch—it involves complex brain pathways including the hypothalamus, limbic system, and prefrontal cortex working together. Research on bremelanotide revealed that activating melanocortin receptors (MC4R) in the hypothalamus increases dopamine activity, promoting:
- Motivation, anticipation, and interest in sexual activity
- Enhanced responsiveness to erotic cues
- Restored sense of “wanting” intimacy
This brain-first approach represents a paradigm shift. Rather than treating symptoms or relying solely on hormone replacement, these interventions target the neurological source of desire itself.
The Power of Oxytocin in Sexual Connection
Oxytocin—often called the “bonding hormone”—plays a crucial role in how women experience intimacy. Released during physical touch, emotional closeness, and orgasm, oxytocin promotes feelings of safety, trust, and connection with a partner.
For many women, desire isn’t just about neurochemical arousal—it’s about emotional readiness. Feeling safe, connected, and valued by a partner creates the psychological conditions where desire can emerge. Interventions that support oxytocin pathways address this relational dimension of sexuality that purely physical treatments miss.
Psychological Approaches with Strong Evidence
Mindfulness-based cognitive therapy shows significant benefits for women with low desire. An 8-week program focusing on present-moment awareness during sexual encounters, reducing rumination about performance, and cultivating self-compassion produced improvements sustained at 12-month follow-up.
Cognitive behavioral therapy targeting maladaptive thoughts about sex, communication skills, and gradual exposure to avoided sexual activities also demonstrates strong efficacy. These approaches work especially well combined with medical treatment.
Introducing Libida™: A Dual-Pathway Solution for Women’s Desire
How Libida™ Works: The Science Behind Dual Action
Libida™ represents the first women-first libido solution combining bremelanotide and oxytocin in a single sublingual formulation. This dual-pathway approach addresses both the neurochemical spark of desire AND the emotional connection pathways that shape how women actually experience arousal.
Bremelanotide activates melanocortin receptors in the hypothalamus, boosting dopamine activity. This translates to:
- Increased motivation and drive
- Sexual thoughts and anticipation
- Responsiveness to erotic cues
- Restored sense of “wanting” intimacy
The active ingredient is FDA-approved injectable form for premenopausal women with acquired, generalized HSDD.
Oxytocin enhances emotional bonding and connection, supporting:
- Relaxation into intimacy
- Feelings of closeness and trust
- Emotional safety and readiness
- Relational warmth that primes desire
Together, these compounds address the reality that women’s sexuality involves both biological drive and emotional context—something male-designed medications have historically ignored.
Effortless Use: On-Demand and Non-Invasive
Unlike daily pills requiring complete alcohol abstinence or injectable medications with 40% nausea rates, Libida™ offers practical convenience. The tiny sublingual lozenge dissolves under your tongue before anticipated intimacy.* Effects may last 24-72 hours, meaning a single dose can support an entire weekend away with your partner.
No needles. No daily regimen. No alcohol restrictions. Just on-demand support when you want it.
*Consult with your Inner Balance provider for personalized guidance on timing and use.
Non-Hormonal and Compatible
Because Libida™ works through brain pathways rather than hormone receptors, it’s compatible with any hormonal status. You can use it whether you’re premenopausal, perimenopausal, or postmenopausal. It complements Oestra™ beautifully for women who’ve optimized their hormones but still experience flat desire, or it works standalone for women whose hormonal health is fine but neurological desire pathways need activation.
Comparing Libida™ to Other Libido Treatments
Libida™ vs. Vyleesi: Needles vs. Lozenges
Vyleesi (bremelanotide injection) requires subcutaneous self-injection into the abdomen or thigh at least 45 minutes before sexual activity. Clinical trials showed 40% of women experienced nausea—most commonly after the first dose but potentially with every use.
Libida™ contains the same FDA-approved active ingredient but delivers it sublingually, eliminating injection anxiety and the nausea often triggered by subcutaneous administration. The addition of oxytocin provides emotional-connection benefits Vyleesi lacks entirely.
Cost matters too: Vyleesi runs approximately $250 per injection, while Libida™ starts at approximately $8-10 per experience with subscription pricing.
Libida™ vs. Addyi: Alcohol Restrictions and Daily Dosing
Flibanserin (Addyi) works through different brain mechanisms—serotonin modulation rather than melanocortin activation. It requires daily dosing at bedtime and comes with a serious constraint: complete alcohol abstinence due to severe hypotension and syncope risks.
For many women, eliminating all alcohol indefinitely proves impractical. Social situations, celebrations, and simple enjoyment of wine with dinner become off-limits. Addyi previously had tighter REMS distribution requirements, but those restrictions were removed; it still carries a boxed warning and requires careful counseling on alcohol timing and drug interactions.
Side effects including dizziness (11.4%), sedation (11.2%), and nausea (10.4%) affect the majority of users. If no improvement occurs after 8 weeks, FDA guidance recommends discontinuation.
The Unique Advantage of Oxytocin
No other available treatment combines desire activation with emotional bonding support. This dual approach reflects clinical understanding that women’s sexuality involves complex interplay between biological drive and relational context. Oxytocin’s role in fostering connection, safety, and trust addresses the reality that many women experience “responsive desire”—arousal that emerges within the context of emotional intimacy rather than spontaneously.
Who Can Benefit from Libida™: Identifying the Ideal Candidate
When Your Spark Feels Gone
Libida™ is designed for women who experience:
- Desire that feels muted, disconnected, or entirely absent
- Loss of sexual fantasies and anticipation
- Loving their partner but never “feeling like it”
- Hormones addressed but desire still flat
- Distress about changes in their sexuality
If you identify with statements like “I used to feel desire, and now it’s just… gone” or “My body works fine, but I never think about or want sex,” you may benefit from targeted neurological support.
Beyond Hormones: Addressing Persistent Low Desire
For women already using hormone therapy who’ve seen improvements in sleep, mood, and energy but still lack sexual desire, Libida™ provides the missing piece. Hormonal optimization creates the foundation; neurological activation restores the spark.
This positioning makes Libida™ complementary to Oestra™ rather than a replacement. The comprehensive Inner Balance ecosystem addresses hormone imbalance at its root (Oestra™) while providing targeted desire support (Libida™) when needed.
Important Considerations: Who Should Not Use Libida™
Libida™ is not appropriate during pregnancy or breastfeeding, for women with uncontrolled hypertension, or those with certain cardiovascular conditions. A telehealth consultation with Inner Balance providers ensures you’re an appropriate candidate before prescribing.
The Inner Balance Approach to Women’s Hormonal and Sexual Health
Redefining Women’s Healthcare
Inner Balance was founded on the belief that women deserve to be believed by their doctors. Too many women have been told their symptoms are “just stress,” “just aging,” or “just in your head.” Founded by Dr. Sarah Daccarett, MD—a board-certified physician specializing in women’s hormonal health and longevity medicine—Inner Balance provides physician-led, evidence-based care through convenient telehealth.
The platform addresses the full spectrum of hormonal concerns: perimenopause, menopause, endometriosis, PCOS, and postpartum hormonal changes. Licensed in all 50 states, Inner Balance brings specialized hormone care to women regardless of location.
Bioidentical Hormones: Precision Treatment for Systemic Wellness
For women whose low libido stems from hormonal imbalance, Oestra™ vaginal hormone cream delivers compounded bioidentical estradiol and progesterone with 4x the bioavailability of oral forms. By bypassing liver metabolism, vaginal delivery provides stable hormone levels without the drowsiness and mood swings associated with oral progesterone.
In surveys of Inner Balance users, 97% of women reported improvement in vaginal dryness and 75.3% experienced better sex drive and arousal with Oestra™. When hormonal optimization alone isn’t enough, adding Libida™ addresses the neurological dimension.
Symptom-Based Treatment, Not Lab-Driven
Labs can be helpful but aren’t always precise, which is why we focus on treating your symptoms and how you feel. Are you sleeping better? Is your mood more stable? Has your desire returned? These lived experiences guide treatment decisions.
Integrating Libida™ into Your Wellness Plan
Libida™: The Missing Piece for Optimized Desire
Think of your sexual wellness as having multiple layers:
- Hormonal balance forms the foundation—ensuring your brain has the chemical building blocks for desire
- Neurological activation through Libida™ ignites the spark
- Emotional connection and relational wellness complete the picture
For women starting their Inner Balance experience, addressing hormonal imbalance with Oestra™ often restores desire naturally. But if desire lags even after hormones are optimized—if you feel physically healthier but still disconnected from your sexuality—Libida™ provides targeted support exactly when you need it.
Personalized Support for Lasting Results
Inner Balance provides:
- Unlimited access to healthcare experts
- Personalized treatment plans with ongoing dose adjustments
- Regular check-ins for symptom monitoring
This isn’t one-size-fits-all medicine. Your care team helps you determine whether hormonal optimization, neurological support, or both will best address your unique situation.
Starting is simple: complete a five-minute online health assessment, receive physician approval within 24-48 hours, and have medications shipped directly to your home.
Libida™ is a brain-based libido booster for women – no hormones, meds, or injections. One dissolvable tablet to bring the spark back, on your terms.
HSA/FSA Eligible •
Free shipping • Cancel anytime
Frequently Asked Questions
How quickly can I expect results with Libida™, and how often can I use it?
Libida™ begins working approximately 45-60 minutes after sublingual administration, with effects that may last 24-72 hours. Unlike daily medications, it’s used on-demand when you anticipate intimacy. You can use Libida™ as needed, though most women find occasional use sufficient given the extended duration of effects.
Is Libida™ compatible with hormone therapies like Oestra™?
Yes, Libida™ is non-hormonal and works through brain pathways rather than hormone receptors. It’s designed to complement hormonal optimization. Many women find that Oestra™ restores their foundational hormonal health while Libida™ provides the neurological activation that transforms wanting into actually wanting.
What’s the difference between HSDD treatments that target the brain versus hormones?
Hormonal treatments like testosterone or estrogen address tissue health, receptor sensitivity, and foundational neurotransmitter activity. Brain-targeting treatments like bremelanotide directly activate desire pathways in the hypothalamus, boosting dopamine to restore the mental experience of wanting. Most women with persistent low desire benefit from addressing both dimensions.
Are there side effects I should know about with Libida™?
The sublingual formulation typically produces fewer side effects than injectable bremelanotide. Some women experience temporary flushing or mild nausea. Libida™ is not appropriate during pregnancy, breastfeeding, or for women with uncontrolled hypertension or certain cardiovascular conditions. Your Inner Balance provider will review your complete health history to ensure it’s right for you.
How does the cost of Libida™ compare to other prescription libido treatments?
Libida™ offers significant value compared to alternatives. At approximately $8-10 per experience with subscription pricing ($199/month for 10 tablets), it costs a fraction of injectable Vyleesi ($250/injection). One-time purchase options are also available at $249 for 10 tablets. HSA/FSA eligible.
